Neosem Inc (253590) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Neosem Inc stock KRW 1,751, price KRW 12,900, that is 86.4% below the price, quality 41 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range 2,513 KRW – 20,650 KRW · fair‑value band 1,751 KRW – 1,827 KRW · the 12,900 KRW price screens above the 1,751 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 7, 2026.
Follow Neosem in your weekly email
Every Wednesday you see whether Neosem is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Neosem Inc. manufactures and sells semiconductor inspection equipment. It offers memory burn-in, SSD, DRAM module, and LED tests; surface particle detectors; and automation test systems. The company was founded in 2002 and is headquartered in Anyang-si, South Korea.
Stock analysis
Neosem Inc (253590) currently trades at 12,900 KRW, while our model-based Fair Value estimate is 1,751 KRW, 86% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 2,977 KRW per share, and 0 of the 16 models we run sit above the 12,900 KRW price.
Bear case: the Dividend Discount group reads lowest at 588.41 KRW, and 16 of the 16 models stay below the price. Data coverage for this calculation is low.
Scenario range: 1,751 KRW (bear) to 1,827 KRW (bull), the price of 12,900 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 41/100 (below-average quality), in the Technology sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Neosem Inc reported revenue of 63.9B KRW in FY2025 versus 37.2B KRW in FY2021, a compound +14.5%/yr. Reported net income was 5.3B KRW in FY2025, compounding −1.4%/yr from FY2021.
Key figures
Market cap 555B KRW (≈ $414M) Small · P/E ratio 45.5 · P/S ratio 6.66 · EPS (TTM) 376.53 KRW · Dividend yield 0.8% · Net margin 19.5% · Return on equity 13.2% · Return on assets (EBIT) 6.7% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 65 out of 100 (low confidence).
What moves the price
The share trades about 38% below its 52-week high and 87% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at −12% fair-value upside, at −86%, 253590 screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (561.38 KRW to 7,750 KRW). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear1,751 KRWFair Value 1,751 KRWBull1,827 KRW
Price 12,900 KRW · Downside -86.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (237.89 KRW per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.25/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−39.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.6%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.3%
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−7.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−7.8%
Dividend (yield on the price)0.8%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.25% → 6%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Semiconductors · 370 stocks
Beats the industry median on 5/13 measures
Overall it trails its industry peers.
Valuation
Quality Score41 · Bottom 25%
Fair Value upside−86.4% · Bottom 25%
Profitability
Return on equity (12 months)13.2% · Above median
Return on assets3.5% · Above median
Net margin (12 months)19.5% · Above median
Operating margin (12 months)31.7% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)120.5% · Top 25%
Dividend yield (12 months)0.8% · Below median
Balance sheet
Debt / equity0.16× · Above median
Valuation Multiplesvs Semiconductors median · lower = cheaper
P/E (12 months)45.5× · Pricier than median
P/B4.65× · Pricier than median
P/S (12 months)6.66× · Pricier than median
EV/EBITDA34.1× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 100
PAST (return on equity)53· sector 27
HEALTH (low debt)92· sector 96
DIVIDEND (yield)16· sector 20
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Neosem Inc Fair Value". https://www.fairvalue-calculator.com/stock/253590
Frequently asked questions
Is Neosem Inc (253590) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of 1,751 KRW versus a price of 12,900 KRW, about 86% lower (overvalued).
What is the fair value of 253590?
Our model-based fair value for Neosem Inc is 1,751 KRW (as of Nov 7, 2026), built from audited fundamentals. The current price: 12,900 KRW.
What is the quality score of 253590?
Neosem Inc has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Neosem Inc (253590)?
Our model-based price target is the fair value of 1,751 KRW (as of Nov 7, 2026) from 16 valuation models. Cautious scenario 1,751 KRW, optimistic scenario 1,827 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Neosem Inc stock forecast for 2026?
Our models put fair value at 1,751 KRW, about 86% lower versus a price of 12,900 KRW (overvalued). Cautious scenario 1,751 KRW, optimistic scenario 1,827 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Neosem Inc (253590)?
Neosem Inc reported trailing-twelve-month revenue of about 83.3B KRW (latest available figure, as of Nov 7, 2026).
Does Neosem Inc pay a dividend?
Neosem Inc currently shows a dividend yield of 0.78% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of Neosem Inc (253590) and when is the ex-dividend date?
Neosem Inc pays a dividend of 100.00 KRW per share a year, a dividend yield of 0.8%. The last ex-dividend date was Dec 29, 2025. A dividend has been paid every year since at least 2019. The payout ratio is 26.6% of earnings. Our assessment: Token dividend. At a yield of 0.8% the dividend is symbolic. On paper it is not fully covered by earnings or free cash flow, but at this size that hardly matters: even scrapping it entirely would cost less than 0.8% a year, and coverage ratios on amounts this small swing with ordinary working-capital movements. Judge this company on its business, not on its dividend.
What is the intrinsic value of Neosem Inc (253590)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Neosem Inc it is 1,751 KRW per share (as of Nov 7, 2026), against a price of 12,900 KRW. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Neosem Inc stock overvalued or undervalued in 2026?
As of Nov 7, 2026, 253590 trades above its calculated fair value: price 12,900 KRW, fair value 1,751 KRW, a gap of about −86% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 253590?
No. The price is what the market pays today (12,900 KRW); the fair value is what the company's own numbers justify (1,751 KRW). For Neosem Inc the two are 11,149 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Neosem Inc worth?
The market values Neosem Inc at about 555B KRW (market capitalisation, as of Nov 7, 2026). Per share that is 12,900 KRW; our models calculate a fair value of 1,751 KRW per share.
What do the bullish and bearish scenarios say about 253590?
Our models span a range for Neosem Inc: cautious scenario 1,751 KRW, base 1,751 KRW, optimistic 1,827 KRW per share (as of Nov 7, 2026, price 12,900 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 253590?
Neosem Inc trades at a price-to-earnings ratio of 45.5 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 1,751 KRW is built from several models across several years. Median P/E at fiscal year-end, 7 fiscal years (2018 to 2025), reported earnings: 23.3. Other multiples: P/B 4.7, P/S 6.7, EV/EBITDA 34.1.
How solid is the balance sheet of Neosem Inc (253590)?
Balance-sheet figures for Neosem Inc (as of Nov 7, 2026): return on equity 13.2%, debt of 0.16 per unit of equity. They feed the Quality Score of 41/100, which measures business quality independently of the share price.
How far is 253590 from its 52-week high?
Neosem Inc trades at 12,900 KRW, about 38% below its 52-week high of 20,650 KRW and 87% above the low of 6,900 KRW (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 1,751 KRW is for.
Which stocks are comparable to Neosem Inc?
From the same area (Technology) we also value NVIDIA Corporation, Taiwan Semiconductor Manufacturing Company, Broadcom Inc, Micron Technology, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Neosem Inc stock attractive at the current price?
The data as of Nov 7, 2026: price 12,900 KRW, calculated fair value 1,751 KRW (−86%), Quality Score 41/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 253590 calculated?
We run Neosem Inc through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 1,751 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.7% above its aggregate fair value. Neosem Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Neosem Inc (253590)?
The closing price on Nov 9, 2026 was 12,900 KRW. Our model-based fair value is 1,751 KRW, about 86% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Neosem Inc right now?
The price sits above even our optimistic bull case (1,827 KRW). The favourable scenario is already priced in. Weak quality (41/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. The models converge in a tight band (1,751 KRW to 1,827 KRW), unusually little disagreement for a valuation.
Key figures of Neosem Inc
How large is the market capitalisation of Neosem Inc (253590)?
The market capitalisation of Neosem Inc is 555B KRW (≈ $414M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Neosem Inc (253590)?
The price-to-sales ratio of Neosem Inc is 6.66 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Neosem Inc (253590)?
Earnings per share at Neosem Inc are 376.53 KRW (price ÷ EPS = P/E 45.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Neosem Inc (253590)?
The dividend yield of Neosem Inc is 0.8% (payout 26.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Neosem Inc (253590)?
The net margin of Neosem Inc is 19.5% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Neosem Inc (253590)?
The return on equity (ROE) of Neosem Inc is 13.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Neosem Inc (253590)?
On an EBIT basis the return on assets of Neosem Inc is 6.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Neosem Inc (253590)?
The operating margin of Neosem Inc is 31.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Neosem Inc (253590)?
Revenue at Neosem Inc is growing +121% versus a year earlier (3y avg −5.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Neosem Inc (253590)?
Earnings per share at Neosem Inc are growing +32.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Neosem Inc (253590) generate?
The free cash flow of Neosem Inc is −12.9B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Neosem Inc (253590) carry?
The net debt of Neosem Inc is 3.0B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Neosem Inc in the live analysis
One click puts Neosem Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 7, 2026